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SUMMARY
A small molecule that safely mimics the ability of dietary restriction (DR) to delay age-related
diseases in laboratory animals is greatly sought after. We and others have shown that resveratrol
mimics effects of DR in lower organisms. In mice, we find that resveratrol induces gene expression
patterns in multiple tissues that parallel those induced by DR and every-other-day feeding. Moreover,
resveratrol-fed elderly mice show a marked reduction in signs of aging including reduced
albuminuria, decreased inflammation and apoptosis in the vascular endothelium, increased aortic
elasticity, greater motor coordination, reduced cataract formation, and preserved bone mineral
density. However, mice fed a standard diet did not live longer when treated with resveratrol beginning
at 12 months of age. Our findings indicate that resveratrol treatment has a range of beneficial effects
in mice but does not increase the longevity of ad libitum-fed animals when started mid-life.
INTRODUCTION
In developed countries, much of the population now survives to the point where chronic age-
associated diseases such as cardiovascular disease, cancer, diabetes, sarcopenia, osteoporosis,
stroke, and kidney disease are major determinants of morbidity and mortality (Crews, 2005).
Numerous studies have shown that dietary restriction (DR) alleviates many of these conditions
in mammals. Reduction of caloric intake to 30–50% below ad libitum levels, or every-other-
day feeding (EOD) of a nutritious diet, can delay the onset of age-related diseases, improve
stress resistance, and decelerate functional decline (Barger et al., 2003; Goodrick et al.,
1982; McCay et al., 1935). Although DR has beneficial effects in humans (Heilbronn et al.,
2006), such a diet is unlikely to be widely adopted, and would pose a significant risk to the
frail, critically ill, or the elderly. As such, we have focused on the development of “DR mimetic”
compounds that provide some of the benefits of DR without a reduction in caloric intake
(Ingram et al., 2004). Strategies that have been proposed, include inhibition of glycolysis (2-
deoxyglucose) (Lane et al., 1998), enhancing insulin action (glucophage/metformin) (Dhahbi
et al., 2005), and small molecule activators of SIRT1 (e.g. 3,5,4’-trihydroxystilbene/
resveratrol) (Howitz et al., 2003).
Sirtuins are a family of NAD+-dependent deacetylases and ADP-ribosyltransferases that are
homologous to the Saccharomyces cerevisiae Sir2 protein. Extra copies of SIR2 or its homologs
extend lifespan in yeast (Kaeberlein et al., 1999), worms (Tissenbaum and Guarente, 2001),
and flies (Rogina and Helfand, 2004) and are proposed to underlie some of the physiological
effects of DR in simple organisms (Anderson et al., 2003; Lin et al., 2000) and in mammals
(Boily et al., 2008; Bordone et al., 2007; Chen et al., 2005). To study sirtuins in mammals, we
employed resveratrol, a small polyphenol identified in an in vitro screen for SIRT1 activators
that can extend the lifespan of S. cerevisiae (Howitz et al., 2003; Jarolim et al., 2004),
Caenorhabditis elegans (Viswanathan et al., 2005; Wood et al., 2004), Drosophila
melanogaster (Bauer et al., 2004; Wood et al., 2004) and the vertebrate fish Nothobranchius
furzeri (Valenzano et al., 2006), although one group has failed to detect a significant effect in
worms or flies (Bass et al., 2007). In the first three species, lifespan extension is dependent on
SIR2, and this has not yet been tested for N. furzeri. In obese mice, resveratrol improves a
number of health parameters including glucose homeostasis, endurance, and survival (Baur et
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al., 2006; Lagouge et al., 2006; Sun et al., 2007), at least partly due to the increased activity of
SIRT1 and AMPK (Baur et al., 2006; Lagouge et al., 2006).
Here, we test the hypothesis that resveratrol imparts health benefits by inducing DR physiology.
At one year of age, C57BL/6NIA mice were placed on a standard control diet (SD) or DR by
every-other-day feeding (EOD) with or without resveratrol. We present evidence that long-
term resveratrol treatment slows age-related degeneration and functional decline and mimics
the gene expression patterns induced by DR. We discuss the potential implications of these
findings for human health.
RESULTS
We previously reported that resveratrol improves the health and survival of obese mice fed a
high calorie diet (Baur et al., 2006). This raised two key questions: Can resveratrol improve
the health of non-obese mice and if so, is this due to an ability to mimic the effects of DR? To
answer these questions, we examined the effects of resveratrol on mice fed a standard diet (SD)
ad libitum, subjected to every-other-day feeding (EOD), or fed a high calorie diet (HC) ad
libitum. Initially, each dietary group was divided into no resveratrol (negative control; SD,
EOD, or HC), low resveratrol (100 mg/kg of food, SDLR, EODLR, or HCLR), or resveratrol
(400 mg/kg of food, SDR, EODR, or HCR). Later, additional groups of mice were given a
higher dose of resveratrol along with the standard or HC diets (2400 mg/kg of food, SDHR or
HCHR). The HC plus resveratrol (HCR) group was the subject of a previous report, and that
nomenclature is preserved herein (Baur et al., 2006).
Resveratrol mimics transcriptional effects of DR
One of the most comprehensive ways to assess global changes in physiology is to compare
transcriptional changes across major organs and tissues (Spindler, 2006). To test the hypothesis
that resveratrol is a mimetic of DR, we compared the transcriptional profiles of resveratrol and
EOD feeding in liver, skeletal muscle, adipose, and heart. Z ratios were calculated for each
gene as described previously (Cheadle et al., 2003), and false discovery rates were estimated
using Rankprod (Hong et al., 2006). A subset of the expression changes was verified by RT-
PCR (Figure S1). Most transcriptional changes induced by resveratrol were subtle (fold change
< 1.5) and tissue-specific. The ten largest changes induced by resveratrol treatment in each
tissue are listed in Table S1. In liver Cyp7A1, a rate-limiting enzyme in the conversion of
cholesterol to bile acids (Russell and Setchell, 1992), was upregulated, while glucose-6-
phosphatase, a rate limiting enzyme in the production of glucose (Trinh et al., 1998), was
repressed. In skeletal muscle and heart, numerous transcripts involved in contractility were
altered, while in white adipose tissue (WAT) the most prominently affected transcripts were
beta defensins, antimicrobial peptides involved in innate and adaptive immunity (Bowdish et
al., 2006). The two changes that were consistent across all four tissues based on the Rankprod
analysis were reductions in the expression of the anion exchanger Slc4a1, and the interferon-
inducible transcript Ifi27/Isg12, which could indicate suppression of inflammatory responses.
Microarray data on the effects of SIRT1 overexpression in these tissues are not available,
making it currently difficult to assess whether SIRT1 is a mediator of these effects. No global
correlation with previous studies of SIRT1 overexpression in cultured NIH3T3 or beta-cells
(Moynihan et al., 2005; Revollo et al., 2004) was observed (data not shown).
To test the hypothesis that resveratrol treatment induces global transcriptional changes that
resemble EOD feeding, we performed principal component analysis (PCA) on the microarray
data from each tissue. Each principal component (PC) can be roughly considered to represent
a set of correlated changes in gene expression, and to be independent of every other PC. PCs
are ranked based on the contribution each makes to the total variability between samples. When
the entire data set is used to generate principal components, the effects of age and diet
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predominate (data not shown), however an effect of resveratrol treatment can also be observed
that parallels the changes induced by EOD feeding. If the SD, SDR, and EOD groups are used
for PCA (eliminating the influence of age and HC diet), the effects of resveratrol and EOD
feeding correlate in the first PC (i.e. the set of correlated changes making the greatest
contribution to variability between groups) in liver, muscle, and adipose. Restricting the
analysis to differentially expressed genes strengthens the correlation considerably (see panels
1A (liver vs. muscle) and 1B (adipose vs. heart)).
To comprehensively measure the variability between groups, we calculated pairwise distances
in high-dimensional space. The position of each data point (microarray) is specified by the
expression levels of many different genes, each represented mathematically as a distance in an
independent spatial dimension; a straight line connecting any two points can always be drawn,
and its length is a reflection of the similarity between the two microarrays in question. Such
calculations were performed for each pair of microarrays in each tissue, and the results are
presented in Figure 1C, with deep red representing a high degree of similarity, and white
representing divergent samples. These calculations also allow a statistical evaluation of the
hypothesis that resveratrol treatment shifted the overall pattern of gene expression toward that
induced by EOD feeding. This conclusion could be reached based on spatial distances for liver,
muscle, and heart. The statistical power in adipose tissue was limited by the number of samples,
although the same trend was apparent. Thus the transcriptional effects of resveratrol and EOD
feeding show significant overlap in multiple tissues.
Although EOD feeding and conventional caloric restriction (reducing daily energy intake by
~40%, “CR”) share key features, including extending mean and maximum lifespan, preventing
age-related disease, and improving insulin sensitivity, they have not been shown to work
through a common mechanism. Therefore, we were interested in comparing our transcriptional
profiles of EOD and resveratrol treatment to previously reported effects of CR. Differences in
age, strain, gender, duration of treatment, array platform, and tissue compound this analysis.
Nonetheless, by testing the overlap based on differential expression signatures (Swindell,
2008), we detected significant associations between either EOD feeding or resveratrol
treatment and previous studies of caloric restriction (Figure 1D). In the case of liver, the effects
of EOD and resveratrol treatment overlapped significantly with those of CR for 5 of 7 published
studies.
We next used parametric analysis of gene-set enrichment (PAGE) to highlight specific
functional pathways within the microarray data. Gene sets were obtained from the Molecular
Signatures Database (MSigDB, C2 collection) and analyzed as described previously
(Subramanian et al., 2005). Pathways that were significantly altered by EOD feeding or
resveratrol treatment are presented in Figure 2A. The effects of the two treatments were
correlated (by direction of change) in 82% (liver), 76% (muscle), 96% (adipose), and 64%
(heart) of the affected pathways, supporting the idea that resveratrol can mimic many effects
of DR in vivo. Among the notable changes were an increase in mitochondrial gene expression
in liver and muscle (Figure 2B) and a decrease in apoptosis across the four tissues (Figure 2C).
Full names and Z scores for the gene sets in Figures 2 and S2 are presented in Table S5.
We also sought to identify changes in gene expression patterns that occur during normal aging
and to test whether resveratrol treatment or DR resulted in more youthful gene expression
patterns in the elderly mice. Based on a comparison between SD fed mice at 18 and 27 months
of age, gene expression patterns induced by either resveratrol treatment or EOD feeding in
liver resembled patterns from mice nine months younger (Figure 2D), while in muscle this was
only true for resveratrol treatment. In adipose both EOD feeding and resveratrol enhanced
changes that occurred with aging, while in heart, neither treatment had a significant effect.
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These results indicate that both resveratrol and EOD feeding can slow the transcriptional
changes that occur with aging in some but not all tissues.
We previously showed that resveratrol opposes the majority of the transcriptional changes in
liver induced by a high calorie (HC) diet. Using newly isolated RNA, a different array platform,
and the current version of the MSigDB pathways (1687 pathways vs. 522 analyzed previously),
we have confirmed this result and extended our analysis to three additional tissues: skeletal
muscle, adipose, and heart (Figure S2). These results from additional tissues support the
conclusion that resveratrol treatment induces gene expression profiles that resemble mice on
a lower calorie diet.
Resveratrol delays functional decline
Osteoporosis is a major age-associated disease in humans (Gass and Dawson-Hughes, 2006).
Resveratrol increases the osteogenic response of osteoblasts (Su et al., 2007) and bone density
in ovariectomized rats (Liu et al., 2005), but the effect of resveratrol on age-induced bone loss
in normal mice has not previously been tested. Following their natural deaths, femurs were
removed from mice (ages 30–33 months) and analyzed by micro-computed tomography (micro
CT) and mechanical measurements. In the distal femur, resveratrol significantly improved the
tissue mineral density (TMD) in SDLR and SDR compared to SD control bones (Figure 3A),
and tended to increase trabecular thickness (P = 0.13). Cortical TMD (Figure 3B) trended
higher in resveratrol-treated groups (P = 0.14), and the effect was statistically significant when
the two doses were pooled. In addition, resveratrol significantly increased the bone volume to
total volume ratio over the entire femur in the SD fed mice (Figure 3C). Bone strength was
determined as the load that is endured by a bone prior to failing in the 3 point bend test.
Resveratrol caused a trend towards increased maximum load (P = 0.18, Figure 3D), that
approached statistical significance when the two doses were pooled (p = 0.058). Overall,
resveratrol improved the structure and strength of the femurs tested, suggesting that it may
improve bone health.
The development of age-related cataracts involves mis-migration of lens epithelial cells and
the accumulation of reactive oxygen species (Wolf et al., 2005). A pathologist trained in
cataract assessment in aging mice, and blinded to the groups, rated lens opacity in live mice
from 0 to 4 by half steps of 0.5, with 4 representing the complete lens opacity of a mature
cataract. Consistent with previous studies (Wolf et al., 2000), the extent of cataract formation
significantly increased with age in ad libitum-fed mice (Figure 3E). Strikingly, this increase
was attenuated by resveratrol treatment, which was more effective than EOD at 30 months of
age.
Decreased locomotor function resulting in the loss of balance and coordination occurs with
increasing age in humans and rodents. To test the effect of resveratrol on locomoter function,
we measured the time to fall from an accelerating rotarod every 3 months. Rotarod is a task
that contains a learning component (Welsh et al., 2005), so it is normal to observe improved
performance over time. The SDR group, however, showed a pronounced and statistically
significant improvement at 21 and 24 months (Figure 3F), indicating that resveratrol improves
balance and motor coordination in aged animals.
Improved vascular function
Increased albuminuria is a marker of vascular dysfunction in mice and a clinical marker of
overall increased cardiovascular risk in humans (Guzik and Harrison, 2007; Scalia et al.,
2007). Urine albumin/creatinine ratios were assessed in the SD, HC, HCLR and HCR groups
at 21 and 26 months of age. The HC mice, but not the HCLR or HCR mice, had significantly
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increased albumin/creatinine ratios compared to SD controls at both time points (Figure S3A),
indicating that resveratrol affords protection against vascular or kidney dysfunction.
Because the original cohort had reached an advanced age and had few members remaining, we
assessed vascular function in an additional cohort of mice placed on a diet containing 2400
mg/kg resveratrol at 12 months of age. Total plasma cholesterol was significantly reduced in
22-month-old non-obese mice (SDHR) following 10 months of resveratrol treatment (Figure
S3B), while plasma triglycerides showed a slight trend toward a decrease (Figure S3C).
Fractionating pooled plasma samples revealed that resveratrol reduced the amount of
cholesterol carried in all lipoprotein fractions (Figure S3D). One potential explanation for the
decrease in circulating cholesterol is diversion to bile acid synthesis via Cyp7A1, which was
highly upregulated in the livers of resveratrol-treated animals (Table S1). However, changes
in bile acid pool sizes were not detected (data not shown).
Aortic dysfunction and stiffening occur with increased age in humans (Lakatta and Levy,
2003; Vaitkevicius et al., 1993), and it has been suggested that resveratrol might be protective
against these effects (Labinskyy et al., 2006). Therefore, we investigated the effects of
resveratrol (2400 mg/kg/food) on vascular function in mice fed a SD or HC diet. Aortas of 3
(SD only) or 18-month old animals were dissected and tested for responsiveness to the
endothelium-dependent vasodilator acetylcholine (ACh). Both age-related and obesity-related
functional decline were prevented by resveratrol treatment (Figure 3G). The responsiveness
of aortas from SDHR mice was significantly better than that of age-matched controls, and
comparable to that of younger (SD 3m) controls. The HC diet significantly worsened
responsiveness, and the HCHR mice were protected such that there was no difference between
HCHR and age-matched SD controls. The loss of ACh-induced relaxation with aging and
obesity was most likely due to increased superoxide production, since pre-incubation of the
HC control vessels with superoxide dismutase restored function (Figure 3G).
To directly measure levels of oxidative stress aortic rings were incubated with dihydroethidine,
which reacts with superoxide to generate the fluorescent molecule ethidium bromide (EB).
Oxidative stress, as measured by EB fluorescence, increased with age, and was attenuated by
resveratrol-treatment in aortas from SD-fed mice (Figure S6P). Separately, mean EB
fluorescence intensities were quantified in cross sections of aortas from the SD 3m, SD 18m,
HC and HCHR mice (Figure S6Q). HC diet increased, and resveratrol attenuated, oxidative
stress, to the point where HCHR aortas were not different from those of age-matched SD
controls. These experiments are summarized in Figure 3H.
Since nitric oxide (NO) is a key mediator of ACh-induced vasorelaxation that is sensitive to
oxidative stress, we measured endothelial nitric oxide synthase (eNOS) expression. The
resveratrol-treated mice displayed increased levels of eNOS mRNA, suggesting an enhanced
capacity for NO production (Figures S6C and S6D), which could potentially help offset
inactivation by superoxide. NADPH oxidase is the primary source of O2.- in vascular tissue
and gp91phox, its catalytic subunit, is up-regulated during aging in endothelial cells (Csiszar et
al., 2007b). Expression of gp91phox was up-regulated in response to aging and HC diet, and in
both cases, the effects were reversed by resveratrol treatment (Figure S6A and S6B). Consistent
with these data, vascular NADPH oxidase activity was increased in mice fed a HC diet, and
this was prevented by resveratrol treatment (Figure S6O). Thus, resveratrol may enhance
vasorelaxation by both increasing NO and decreasing O2.- production.
Apoptotic death of endothelial cells is thought to contribute to vascular pathophysiology in
aging and is attenuated by DR (Csiszar et al., 2004). Since our PAGE analysis suggested that
resveratrol can suppress apoptosis (Figure 2C), we performed TUNEL staining of aortas from
SD 3m, SD 18m, SDHR 18 m, HC 18 m and HCHR 18m mice (Figures 3I and 3J). Apoptotic
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index (TUNEL positive nuclei as a percentage of total propidium iodide stained endothelial
cell nuclei) was increased by aging and further increased by the HC diet, but these increases
did not occur in the presence of resveratrol (Figure 3K).
Inflammatory processes contribute to endothelial dysfunction in aging (Csiszar et al., 2007a)
and obesity (Roberts et al., 2006) and are suppressed by DR. In agreement with in vitro studies
suggesting that resveratrol can reduce the production of inflammatory cytokines and
chemokines through inhibition of NF-κB (Mayo et al., 2003), we found that age- and diet-
related increases in the expression of the inflammatory markers TNFα, IL-6, IL-1β, ICAM-1,
and iNOS were attenuated by resveratrol treatment (Figures S6E- S6N). Consistent with these
observations, we found that a number of pathways containing NF-κB responsive genes were
suppressed in multiple tissues during the PAGE analysis (see Table S5).
Survival
We have reported that resveratrol treatment increased the survival of mice fed a high calorie
(HC) diet to 114 weeks of age (Baur et al., 2006). Here, we provide the complete Kaplan-Meier
survival analysis (Figure 4B–4D) and maximum lifespan (final 20% surviving) for the HC
groups, as well as mice fed a standard diet or placed on an EOD feeding regimen (Figure 4E).
In the context of the HC diet, resveratrol increased remaining lifespan of 1 year old mice by
an average of 26% for the HCLR group (P = 0.005) and 25% for HCR (P = 0.001) to the point
where survival was not significantly different from that of non-obese SD controls. In the lower
dose (HCLR) group, maximum lifespan was also increased, while this effect did not reach
significance for the higher dose (HCR) (Figure 4E). The major factor contributing to lifespan
extension in the resveratrol-treated HC groups was a reduction in the number of deaths
attributed to cardiopulmonary distress (specifically, fatty changes in the liver combined with
severe congestion and edema in the lungs, Table S3).
Interestingly, the increases in longevity could be completely uncoupled from changes in body
weight. While the HCR group had a very slight decrease in body weight that was not statistically
significant, the HCLR group displayed a significant increase in body weight, despite
consuming a similar amount of food (Figures 4A, S4 and S5). Thus, the beneficial effects of
resveratrol on health and lifespan are not dependent on weight loss.
In the context of the standard diet, resveratrol did not increase overall survival or maximum
lifespan (Figures 4B and 4E). Importantly, the SD control group had a lifespan similar to that
of a much larger cohort of C57BL/6NIA mice (Turturro et al., 1999). EOD feeding produced
a trend towards increased longevity compared to the SD control group, but the effect did not
reach statistical significance. Our results are consistent with the previous observation that the
effect of EOD on longevity is diminished in older C57BL/6 mice (Goodrick et al., 1990), which
is also true of DR by 40% restriction (Weindruch and Walford, 1982). Notably, EOD feeding
in combination with the lower dose of resveratrol did extend both mean and maximal lifespan
by 15% compared to SD controls (Figure 4C and 4E). We have also tested the effect of a higher
dose of resveratrol beginning at 12 months of age (SDHR) on lifespan, and again found that
longevity was not significantly affected (Figure 4F).
Histopathology
Blinded post-mortem histopathology for disease or pre-disease states was performed on
visceral organs including the heart, kidneys, liver, spleen, lungs, and pancreas (Table S3).
Resveratrol treatment did not significantly alter the distribution of pathologies in SD groups.
This included neoplasias, despite the potency of resveratrol against implanted or chemically
induced tumors, recently reviewed elsewhere (Baur and Sinclair, 2006). This may be related
to the fact that the vast majority of these cases were lymphomas, a tumor type for which the
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efficacy of resveratrol has not been thoroughly assessed, and that is thought to be triggered
mainly by endogenous retroviruses in mice (Kaplan, 1967;Risser et al., 1983).
DISCUSSION
Here we present a long-term evaluation of resveratrol as a DR mimetic in mice. In agreement
with a concurrent study (Barger et al., 2008), we show that resveratrol induces changes in the
transcriptional profiles of key metabolic tissues that closely resemble those induced by DR. In
liver and muscle, these changes can also be correlated to the gene expression patterns in
younger animals, while in adipose tissue, the trend is reversed. Overall health was improved
under all dietary conditions, as reflected by the reduction of osteoporosis, cataracts, vascular
dysfunction, and declines in motor coordination; however, longevity was increased only in the
context of a HC diet, as reported previously (Baur et al., 2006).
The effects of DR on longevity are diminished when the regimen is initiated at increasing ages
(Goodrick et al., 1990; Weindruch and Walford, 1982), although many of the characteristic
transcriptional changes can be induced rapidly regardless of age (Cao et al., 2001). Indeed, our
EOD feeding regimen was initiated at 12 months of age, and while average lifespan was
increased, the effect did not reach statistical significance, except in combination with
resveratrol (EODLR vs. SD). Thus, it is possible that the age of our animals at the start of the
experiment might have diminished the potential effects of resveratrol on lifespan in non-obese
mice. To address this question we are following up with lifespan studies in which resveratrol
treatment is begun at weaning. It may also be that resveratrol slows the general age-related
decline, but does not impact the specific causes of death in these mice. Indeed, resveratrol did
not suppress lymphoma, a major cause of mortality in C57BL/6 mice.
There is increasing evidence that the anti-aging action of DR, at least in part, stems from the
attenuation of the age-associated increase in oxidative stress (Sohal and Weindruch, 1996). In
particular, DR attenuates oxidative stress in the aortas of aged rodents and this may contribute
to its vasoprotective effects (Guo et al., 2002). Many of the changes we observed in resveratrol-
treated animals involved a generalized reduction in oxidative stress and inflammation,
consistent with known effects of DR. This was particularly apparent in the aorta, where a
decrease in superoxide production was detected directly (Figure 3H), and a variety of
transcripts related to inflammatory processes were repressed (Figure S6E–S6N). These
changes likely had direct functional consequences, since ACh-induced responsiveness was
restored by resveratrol treatment (Figure 3G). In addition, the reduction in cataract formation
in resveratrol-treated animals suggests that oxidative stress was reduced in the eye (Figure 3E).
One clear difference between EOD and resveratrol was that EOD strongly upregulated
glutathione metabolism whereas resveratrol had no effect. Thus, there may be differences in
mechanisms by which EOD and resveratrol reduce oxidative stress. Another difference was
that while both increased expression of ribosomal proteins in liver, heart, and adipose, only
EOD had this effect in skeletal muscle. Since increased protein synthesis in skeletal muscle
has previously been implicated as a major effect of DR (Lee et al., 1999), this result highlights
a potentially important difference in the resveratrol-treated animals.
Whether it is possible to find a DR mimetic that is also safe for long-term consumption is of
considerable debate in the field. Throughout the experiment, mice were subjected to behavioral
tests and examined for signs of distress or disease. Postmortem histopathological assessments
were performed on mice from all three dietary regimens (SD, EOD, and HC), with or without
resveratrol, and no obvious detrimental change was seen. Although we did not find evidence
for detrimental effects of long-term resveratrol treatment at modest doses, we cannot rule out
the possibility that resveratrol exerted harmful effects that limited its ability to extend lifespan.
In a small pilot study using 7.5 times our highest dose (18,000 mg/kg resveratrol in the food),
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5 out of 6 mice died within 3–4 months, consistent with an earlier study of extremely high
doses in rats (Crowell et al., 2004).
In conclusion, long-term resveratrol treatment of mice can mimic transcriptional changes
induced by dietary restriction, and allow them to live healthier, more vigorous lives. In addition
to improving insulin sensitivity and increasing survival in HC mice, we show that resveratrol
improves cardiovascular function, bone density, and motor coordination, and delays cataracts,
even in non-obese rodents. Together these findings confirm the feasibility of finding an orally
available DR mimetic. Since cardiovascular disease is a major cause of age-related morbidity
and mortality in humans but not mice, it is possible that DR mimetics such as resveratrol could
have a greater impact on humans. However, resveratrol does not seem to mimic all of the
salutary effects of DR in that its introduction into the diet of normal one year old mice did not
increase longevity.
EXPERIMENTAL PROCEDURES
Animals and diets
Male C57BL/6NIA were purchased from the National Institute on Aging Aged Rodent Colony
(Harlan Sprague-Dawley, Indianapolis, IN). Beginning at one year of age, mice were fed a
standard AIN-93G diet (SD and EOD) or AIN-93G modified to provide 60% of calories from
fat (HC) plus 0, 0.01%, or 0.04% resveratrol. Average daily doses over the course of the study
(mg/kg/day) were: 7.9 ± 0.2 (SDLR), 30.9 ± 0.6 (SDR), 7.6 ± 0.2 (EODLR), 30.4 ± 0.6 (EODR),
5.4 ± 0.2 (HCLR), 24.2 ± 0.8 (HCR), 204 ± 4 (SDHR), and 167 ± 16 (HCHR, ages 12–18
months). Additional details are provided in the supplemental material.
Micro CT and bone strength
Femurs were removed following natural deaths between the ages of 30–33 months and their
architecture was analyzed on an EVS micro CT MS-8 system (GE Healthcare, London, ON).
Mechanical behavior of the femurs was measured on an ELF 3200 test instrument (Bose Corp,
Eden Prairie, MN). Additional details are provided in the supplemental material.
Cataracts assessment
Age-related lens opacity was scored in all living mice by an experienced pathologist using a
slit lamp, who was blinded as to the experimental groups.
Rotarod
Time to fall from an accelerating rotarod was measured for all survivors from a pre-designated
subset of each group; n = 15 (SD), 11 (SDLR), and 16 (SDR). The mice were tested at 15, 18,
21, and 24 months of age. At each time-point the mice were given a habituation trial at a constant
speed of 4 rpm. The following day each mouse was given three trials, separated by 30 minute
rest periods, during which the rotarod accelerated from 4 to 40 rpm over a period of five min.
Vessel isolation and functional studies
Endothelial function was assessed as described previously (Csiszar et al., 2007a; Csiszar et al.,
2007b). In brief, aortas (n = 6 per group) were cut into ring segments 1.5 mm in length and
mounted in myographs chambers (Danish Myo Technology A/S, Inc., Denmark) for
measurement of isometric tension. The vessels were superfused with Krebs buffer solution
(118 mM NaCl, 4.7 mM KCl, 1.5 mM CaCl2, 25 mM NaHCO3, 1.1 mM MgSO4, 1.2 mM
KH2PO4, and 5.6 mM glucose; at 37°C; gassed with 95% air and 5% CO2). After an
equilibration period of 1 hour during which an optimal passive tension was applied to the rings
(as determined from the vascular length-tension relationship), they were pre-contracted with
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10−6 M phenylephrine and relaxation in response to acetylcholine (ACh) over the range of
10−9 to 10−6 M was measured. In some experiments rings were pre-incubated for 30 min with
200 U/mL superoxide dismutase to test the involvement of oxidative stress.
Apoptosis assays
TUNEL assays were performed on aorta sections using the Apop Tag Fluorescein in Situ
Apoptosis Detection Kit (Chemicon/Millipore, Billerica, MA), according to manufacturer’s
instructions, as previously described (Csiszar et al., 2007b). Endothelial cells were identified
by their anatomical location (Ungvari et al., 2007).
Microarrays
RNA was extracted from liver, muscle, adipose and heart at 18 or 27 months of age and
hybridized to Illumina Mouseref 8 whole genome microarrays (version 1.1). Raw data were
subjected to Z normalization as described previously (Cheadle et al., 2003) and are available
at http://www.ncbi.nlm.nih.gov/geo, accession number GSE11845. Gene set enrichment was
tested using the PAGE method as previously described (Kim and Volsky, 2005) and pathway
definitions from MSigDB (Subramanian et al., 2005). Pathways involving mitochondria and
apoptosis (Figure 2B and 2C) were selected based on the names and descriptions provided by
MSigDB while blinded to the data. Differentially expressed genes were converted into
differential expression signatures and used to evaluate overlap with previously reported effects
of 10–44% CR as described previously (Swindell, 2008). Characteristics of the animals in 10–
44% restriction studies are presented in Table S2. Additional details, including calculation of
principal components and pairwise distances, are provided in the supplemental material.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Resveratrol and dietary restriction have overlapping effects on gene expression
(A, B) Principal component analysis (PCA) was performed on differentially expressed genes
from SD, SDR, and EOD for liver, muscle, adipose, and heart. First PCs (the sets of correlated
changes that capture the most variability between samples) for liver, muscle, and adipose are
presented in panels 1A and 1B. Each shows a shift of the gene expression pattern in resveratrol-
treated animals (SDR) toward that induced by every-other-day feeding (EOD). In heart, the
first PC did not show this effect, however the second PC (shown) was nearly equal and did
reveal a similar shift. Error bars are 95% confidence intervals. (C) Distances were calculated
in high-dimensional space for each pair of samples. Each square shows the distance between
two individual samples, ranging from zero (deep red, see comparisons to self on the diagonal)
to highly divergent (white). In each tissue, distances between SDR and EOD samples (lower
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right portion) tend to be smaller than those to SD samples. P values were determined by
Kruskal-Wallis (nonparametric) one-way ANOVA, and are similar, but slightly more
conservative than those obtained by standard ANOVA. (D) To compare our transcriptional
profiles of EOD and resveratrol treatment to published data on 10–44% caloric restriction
(Corton et al., 2004; Dhahbi et al., 2005; Dhahbi et al., 2006; Edwards et al., 2007; Fu et al.,
2006; Higami et al., 2004; Lee et al., 2002; Selman et al., 2006; Tsuchiya et al., 2004), we
generated differential expression signatures (Swindell, 2008). For each pair of transcriptional
profiles, the significance of the overlap in expression changes was evaluated by permutation
testing and adjusted for multiple comparisons using the Benjamini-Hochberg method
(Benjamini and Hochberg, 1995). Publicly available datasets are assigned a name based on the
tissue examined and described in detail in Table S2. Shaded boxes indicate significant
associations (P < 0.05).
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Figure 2. Resveratrol shifts expression patterns in mice on a standard diet towards those of mice
on a calorie restricted diet
(A) Parametric analysis of gene-set enrichment (PAGE) was performed on microarray data
from mice fed a standard diet plus resveratrol (SDR) or subjected to EOD feeding. Columns
show every pathway significantly up-regulated (red) or down-regulated (blue) by either
treatment at 27 months of age. The directions of changes induced by resveratrol and EOD
feeding were highly correlated in liver (82% of 503 pathways), muscle (76% of 398 pathways),
and adipose (96% of 524 pathways), and weakly correlated (64% of 375 pathways) in heart.
(B) The effect of resveratrol and EOD on mitochondria-related pathways from the PAGE
analysis for liver, skeletal muscle, adipose and heart at 27 months of age. (C) The effect of
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resveratrol and EOD feeding on apoptosis-related pathways from the PAGE analysis for liver,
skeletal muscle, adipose, and heart at 27 months of age. Full names and Z scores for each of
the pathways represented in panels B and C are presented in the supplemental material. (D)
PAGE analysis was reexamined to identify changes in transcriptional patterns between control
(SD) mice at 18 and 27 months of age for liver, muscle, adipose and heart. For each of the
pathways found to be significantly different in the 18-month-old (“younger”) mice compared
to 27-month-old mice (359, 270, 365, and 256 pathways in liver, muscle, adipose, and heart,
respectively), the corresponding Z scores are also presented for EOD, SDR, and EODR mice
at 27 months of age (compared to the same 27-month-old controls).
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Figure 3. Resveratrol improves the health of mice fed a standard diet
Femurs were removed following natural deaths between the ages of 30–33 months and
analyzed by micro-computed tomography (micro CT). (A) Distal trabecular tissue mineral
density (TMD) was improved in SDLR and SDR compared to SD control bones (P < 0.05 for
SDLR and P < 0.01 SDR vs SD control; *). All error bars indicate s.e.m. (B) Cortical TMD
tended to increase with resveratrol treatment (p = 0.14). All error bars indicate s.e.m. (C)
Resveratrol significantly increased bone volume to total volume ratio over the entire femur in
SD fed mice (P < 0.05 for SDLR and P < 0.01 SDR vs SD control; *), n = 5 for all groups in
panels A, B, and C. All error bars indicate s.e.m. (D) Bone strength was tested in the post-
mortem femurs. Resveratrol treatment caused a trend towards increased maximum load (the
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load that is endured by a bone prior to it failing in the three-point bending to failure test) (p =
0.18), n = 5 for SD and SDLR and n = 4 for SDR. All error bars indicate s.e.m. (E) Resveratrol
treatment delayed the onset of age-related cataracts. Lens opacity was scored in living mice
on a scale from 0 to 4 by half steps of 0.5, with 4 representing the complete lens opacity of a
mature cataract. Age-related cataract development was significantly decreased at 30 months
of age in SDR mice compared to the SD control, whereas EOD feeding caused an early
protective effect that was lost (P < 0.05; *). All error bars indicate s.e.m. (F) Time to fall from
an accelerating rotarod was measured every 3 months for all survivors from a pre-designated
subset of each group; n = 15 (SD), 11 (SDLR), and 16 (SDR). The SDR group improved
significantly at 21 and 24 months vs. 15 months (P < 0.05; #), showing increased motor
coordination over time. All error bars indicate s.e.m. (G) Acetylcholine-induced relaxation in
aortic ring preparations. Both age-related (SD 18m vs SD 3m) and obesity-related (HC 18m
vs SD 18m) declines in endothelial function were prevented by resveratrol treatment. Pre-
incubation with SOD restored ACh-induced relaxation in the HC 18m rings to youthful levels,
n = 6 for each group. (&P < 0.05 vs. SD 3m, *P < 0.05 vs SD 18m and #P < 0.05 vs. HC 18m).
All error bars indicate s.e.m. (H) Quantification of total nuclear ethidium bromide fluorescence
as a marker of increased oxidative stress, n = 6 aortas for each group. This panel combines data
from two experiments shown separately in Fig. S6P and S6Q. Both age-related (SD 18m vs
SD 3m) and obesity-related (HC 18m vs SD 18m) increases in oxidative stress were prevented
by resveratrol treatment. (&P < 0.05 vs. SD 3m, *P < 0.05 vs. SD 18m and #P < 0.05 vs. HC
18m). All error bars indicate s.e.m. (I, J) Representative TUNEL staining of aortas from mice
of the indicated ages and diets. Nuclei from apoptotic endothelial cells (intense green) in aortas
of SD 18m and HC 18m mice are highlighted in insets. Autofluorescence of elastic laminae
(faint green) and nuclear counterstaining (propidium iodide, red) are shown for orientation
purposes. (K) Apoptotic index (% of TUNEL positive endothelial cell nuclei), was increased
in the aortas of obese mice, and this change was prevented by resveratrol treatment, n = 6 aortas
for each group, 10 to 15 images per aorta were analyzed. (&P < 0.05 vs. SD 3m, *P < 0.05 vs.
SD 18m and #P < 0.05 vs. HC 18m). All error bars indicate s.e.m.
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Figure 4. Effects of resveratrol treatment on longevity
(A) Mean body weights over the entire lifespan. EOD feeding lowered body weight and HC
diet increased it (P < 0.001). Resveratrol did not affect body weight in mice fed the SD or EOD
diets. The HCLR group was significantly heavier than the HC control group (P < 0.01), while
the HCR group showed a slight trend towards decreased body weight that did not reach
statistical significance. Error bars indicate s.e.m. (B) Kaplan-Meier survival analyses were
performed on the SD, SDLR, and SDR groups and the curves were not significantly different
by the log-rank or Wilcoxon tests. n = 60 (SD), 55 (SDLR), and 54 (SDR) at the beginning of
the experiment. (C) Kaplan-Meier survival analyses were performed on the SD, EOD, EODLR,
and EODR groups. There were no significant differences between the three EOD diet groups;
however, the EODLR had increased survival compared to the SD control group as determined
by both log-rank (χ2 = 7.46, P = 0.006) and Wilcoxon (P = 0.0016) tests. n = 60 (SD) and 55
(EOD, EODLR, and EODR) at the beginning of the experiment. (D) Kaplan-Meier survival
analyses were performed on the SD, HC, HCLR, and HCR groups. The HC control group had
decreased survival compared to the SD control group (log-rank: χ2 = 11.65, P = 0.0006,
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Wilcoxon: P = 0.0003), whereas, survival in the HCLR and HCR groups did not differ
significantly from that of SD controls. When compared to HC controls, survival was
significantly increased in both the HCLR group (log-rank: χ2 = 8.31, P = 0.004, Wilcoxon:
P = 0.005) and the HCR group (log-rank: χ2 = 4.83, P = 0.03, Wilcoxon: P = 0.001). n = 60
(SD) and 55 (HC, HCLR, and HCR) at the beginning of the experiment. (E) Maximum lifespan
was calculated as the mean of the final 20% of mice in each group as determined by Kaplan-
Meier analysis. Compared to the SD control group, the maximum lifespan was significantly
increased in the EODLR (P = 0.03) and significantly decreased in the HC control (P = 0.003)
groups. In addition, HCLR had significantly increased maximum lifespan compared to the HC
control group (P = 0.04), and there was a trend towards increased lifespan in HCR mice
compared to HC controls. *,P < 0.05 vs SD control; #, P < 0.05 vs HC control. Error bars
indicate s.e.m. (F) Kaplan-Meier survival analyses were performed on the SD and SDHR
groups, and the curves were not significantly different. The earlier SD survival curve (broken
line) is shown for reference. n = 48 (SD, SDHR), and 60 (previous SD control) at the beginning
of the experiment.
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